Evaluating the antibacterial activity of ceftaroline against clinical isolates of methicillin-susceptible and- resistant Staphylococcus aureus in Kuwait hospitals

• Κύριοι συγγραφείς: Wadha Alfouzan (Συγγραφέας), Samar S. Boswihi (Συγγραφέας), Rita Dhar (Συγγραφέας), Edet Udo (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2020-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Ceftaroline fosamil has been approved by the US Food and Drug Administration for the treatment of skin and soft tissue infections, including those caused by methicillin-resistant Staphylococcus aureus and community-acquired bacterial pneumonia. We evaluated the in-vitro activity of not-in-use ceftar...